Chengdu, China · Founded 2022 · Privately Held (backing)
Developer of nucleic acid-based therapeutic research designed to advance targeted biological interventions. Leaderna Therapeutics is based in Chengdu, China and was founded in 2022. Its last reported valuation was $33.9 million in Dec 2022. It has raised $44.9 million.
Last reported valuation
$33.9M
Oct 2026
Priced at
—
Total raised
$44.9M
Last round
—
Cap table — not yet on record
Leaderna Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Leaderna Therapeutics with a free account
·The complete investor list: 14 names
·Watch Leaderna Therapeutics: the Monday email on marks, rounds and moves
